JEFFREY BOYD: Open Payments
NPI 1023194636 · UMATILLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 28 payments from 10 companies in 2025. Trend: 2023 $993 · 2024 $1,414 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $386 |
| ABBVIE INC. | 8 | $178 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| Exact Sciences Corporation | 2 | $47 |
| PFIZER INC. | 1 | $30 |
| Vifor Pharma, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $16 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, TRELEGY ELLIPTA, Kerendia, The Cologuard Plus Collection Kit, VYNDAQEL, Veltassa.
Industry payments across FL — which companies pay providers there.
